Company: AEMD
Filing Date: 2025-02-12
Form Type: 10-Q
Source: 0001683168-25-000960
Chunk: 69

Company: AETHLON MEDICAL INC
Filing Date: 2025-02-12
Form: 10-Q
Item: Item 8
Chunk 69
---
”),
served as the exclusive placement agent in connection with the offering. We paid Maxim a cash fee of 6.5% of the aggregate gross proceeds
raised at the closing of the offering, and reimbursement of certain expenses and legal fees in the amount of $100,000. We also issued
to designees of Maxim warrants to purchase up to an aggregate of 324,000 shares of common stock (the “Placement Agent Warrants”).
The Placement Agent Warrants have an exercise price of $0.58 per share and have substantially the same terms as the Class A warrants,
except the Placement Agent Warrants are not subject to an exercise price reset, are non-exercisable until November 15, 2024, and will
expire on May 15, 2029.

The gross proceeds from
the offering, before deducting the placement agent’s fees and other offering expenses, were approximately $4.7 million. Net proceeds,
of the offering, after deducting the placement agent fees and expenses and other offering expenses payable by us, were approximately $3.5
million.

The shares of common
stock, the Class A and Class B warrants, the pre-funded warrants and the Placement Agent Warrants described above and the underlying shares
of common stock were offered pursuant to a Registration Statement on Form S-1, as amended (File No. 333-278188), which was declared effective
by the SEC on May 15, 2024.

Warrant Exercises

In June 2024, and holders
of Class A and Class B warrants exercised 300,000 shares and 2,880,000 shares, respectively, for additional proceeds to the Company of
$1,844,400.

 25 

Cash Flows

Cash flows from operating, investing and financing
activities, as reflected in the accompanying Condensed Consolidated Statements of Cash Flows, are summarized as follows:

    (In thousands)  For the nine months ended 

    December 31, 2024  
    December 31, 2023 
  
    Cash (used in) provided by: 

    Operating activities 
    $(5,973) 
    $(7,564)
  
    Investing activities 
     (2) 
     (245)
  
    Financing activities 
     5,368  
     1,245 
  
    Effect of exchange rate changes on cash 
     (10) 
     4 
  
    Net change in